Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety, tolerability and pharmacokinetics of
single and multiple doses of NNI-362 in healthy aged population.